# Clinical Performance of the New Plasma Filter PX2 in TPE Treatments

> **NCT06382675** · NA · RECRUITING · sponsor: **Fresenius Medical Care Deutschland GmbH** · enrollment: 46 (estimated)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DEVICE:** Therapeutic Plasma Exchange (TPE) with the Plasma Filter PX2

## Key facts

- **NCT ID:** NCT06382675
- **Lead sponsor:** Fresenius Medical Care Deutschland GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-18
- **Primary completion:** 2025-12
- **Final completion:** 2026-03
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2025-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06382675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06382675, "Clinical Performance of the New Plasma Filter PX2 in TPE Treatments". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06382675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*